BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29028810)

  • 1. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease.
    Bornheimer R; Shea KM; Sato R; Weycker D; Pelton SI
    PLoS One; 2017; 12(10):e0184877. PubMed ID: 29028810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of community-acquired pneumonia in COPD patients: a population database analysis.
    Müllerova H; Chigbo C; Hagan GW; Woodhead MA; Miravitlles M; Davis KJ; Wedzicha JA
    Respir Med; 2012 Aug; 106(8):1124-33. PubMed ID: 22621820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
    Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
    Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
    Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.
    Graul EL; Nordon C; Rhodes K; Menon S; Al Ammouri M; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
    BMC Pulm Med; 2024 May; 24(1):221. PubMed ID: 38704538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD is associated with increased mortality in patients with community-acquired pneumonia.
    Restrepo MI; Mortensen EM; Pugh JA; Anzueto A
    Eur Respir J; 2006 Aug; 28(2):346-51. PubMed ID: 16611653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
    Dai RX; Kong QH; Mao B; Xu W; Tao RJ; Wang XR; Kong QY; Xu JF
    BMC Pulm Med; 2018 Jan; 18(1):12. PubMed ID: 29357862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics.
    Huerta A; Crisafulli E; Menéndez R; Martínez R; Soler N; Guerrero M; Montull B; Torres A
    Chest; 2013 Oct; 144(4):1134-1142. PubMed ID: 23828375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of community acquired pneumonia with chronic obstructive pulmonary disease: clinical peculiarities, production of active oxygen forms, general antioxidant blood status.
    Farkhutdinov UR; Amirova EF; Farkhutdinov RR
    Ter Arkh; 2019 Mar; 91(3):42-45. PubMed ID: 31094458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
    Yamauchi Y; Yasunaga H; Matsui H; Hasegawa W; Jo T; Takami K; Fushimi K; Nagase T
    BMC Pulm Med; 2015 Jul; 15():69. PubMed ID: 26152178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Community-Acquired Pneumonia on Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Niu Y; Xing Y; Li J; Shui W; Gu Y; Zhang C; Du H
    COPD; 2021 Aug; 18(4):417-424. PubMed ID: 34309464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, bacteriology of endotracheal aspirates and treatment outcomes of patients with chronic obstructive pulmonary disease and community-acquired pneumonia in an intensive care unit in Taiwan with an emphasis on eosinophilia versus non-eosinophilia: a retrospective case-control study.
    Huang WC; Lee CH; Wu MF; Huang CC; Hsu CH; Chen HC; Hsu JY; Huang CC
    BMJ Open; 2018 Sep; 8(9):e020341. PubMed ID: 30206074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COPD on outcomes in hospitalized patients with community-acquired pneumonia: Analysis of the Spanish national hospital discharge database (2004-2013).
    de Miguel-Díez J; López-de-Andrés A; Hernández-Barrera V; Jiménez-Trujillo I; Méndez-Bailón M; de Miguel-Yanes JM; Jiménez-García R
    Eur J Intern Med; 2017 Sep; 43():69-76. PubMed ID: 28615117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza in Malaysian adult patients hospitalized with community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease or asthma: a multicenter, active surveillance study.
    Pang YK; Ismail AI; Chan YF; Cheong A; Chong YM; Doshi P; Lau JZH; Khor J; Wang LPL; Leong CL; Musa AN; Ng KS; Poh ME; Sam IC; Tan JL; Zim MAM; Taurel AF
    BMC Infect Dis; 2021 Jul; 21(1):644. PubMed ID: 34225647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of community-acquired pneumonia in patients with chronic lung disease: a case-control study.
    Dusemund F; Chronis J; Baty F; Albrich WC; Brutsche MH
    Swiss Med Wkly; 2014; 144():w14013. PubMed ID: 25184329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
    Walters JA; Tang JN; Poole P; Wood-Baker R
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.